Skip to Content

TEVA 5526 (Atazanavir Sulfate 150 mg)

Pill with imprint TEVA 5526 is Blue, Capsule-shape and has been identified as Atazanavir Sulfate 150 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Atazanavir is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Atazanavir 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 5526

Atazanavir Sulfate

Imprint
TEVA 5526
Strength
150 mg
Color
Blue
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Protease inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
Manufacturer
Pliva Hrvatska d.o.o.
National Drug Code (NDC)
00093-5526
Inactive Ingredients
D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, ferrosoferric oxide, lactose monohydrate, magnesium stearate, propylene glycol, shellac, sodium lauryl sulfate, sorbitan monolaurate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.